Safety Adverse Event (SAE) Management During Clinical Trial Conduct
 |
|
The accurate and timely capturing and reporting of serious adverse events is a critical component of a successful trial. Ensuring proper safety reporting procedures to sites, institutional review boards (IRB) and competent regulatory authorities is of utmost importance in protecting subjects/patients as well as the integrity of the clinical study results. Therefore, ongoing safety analyses and reporting are vital and require vigilant attention to ensure all serious adverse events are reported in accordance with regulatory requirements.
At Veristat we work with the sites, monitors, sponsors, and investigators to ensure proper and timely reporting of all safety issues, thus helping ensure the safety of trial volunteers. We provide:
Development of the safety management plan inclusive of outlining the safety management responsibilities between Veristat and the sponsor.
Creation of the pregnancy/safety guidelines and forms to ensure proper reporting of pregnancy and SAEs.
Oversight of the build and maintenance of the safety database based on the requiredments of the study specific protocol (in conjunction with the Data Management team).
|
|
While it is critical to ensure patient safety throughout clinical trial planning, execution, and the regulatory approval process, it doesn’t end there. Once a therapeutic receives regulatory approval, long-term safety monitoring begins to ensure continued patient safety.
We can help you develop, negotiate, and implement your Risk Management Plans with the regulatory agencies. The process begins during the preparation of the marketing application (e.g., NDA, NDS, BLA, etc.) and continues post-approval for the entire time the product/therapeutic is on the market.
> LEARN MORE ABOUT PHARMACOVIGILANCE AND SAFETY MONITORING
View the Xtalks webinar replay video to learn an end-to-end approach to bringing a cell and gene therapy to market including key considerations for the ...
A clinical-stage biotechnology start-up asked Veristat to run complex US and EU trials of their unique gene therapy.
There is no “one size fits all” approach to clinical research. Our teams partner with clients to understand their goals in order to plan and execute their clinical ...
